Tissue engineering holds the promise of providing new solutions for heart transplant shortages and pediatric heart transplantation. The aim of this study was to evaluate the ability of a peritoneal-generated, tissueengineered cardiac patch to replace damaged myocardium in a heterotopic heart transplant model. Fetal cardiac cells (1 × 10 6 /scaffold) from syngeneic Lewis rats were seeded into highly porous alginate scaffolds. The cell constructs were cultured in vitro for 4 days and then they were implanted into the rat peritoneal cavity for 1 week. During this time the peritoneal-implanted patches were vascularized and populated with myofibroblasts. They were harvested and their performance in an infrarenal heterotopic abdominal heart transplantation model was examined (n = 15). After transplantation and before reperfusion of the donor heart, a 5-mm left (n = 6) or right (n = 9) ventriculotomy was performed and the patch was sutured onto the donor heart to repair the defect. Echocardiographical studies carried out 1-2 weeks after transplantation showed normal LV function in seven of the eight hearts studied. After 1 month, visual examination of the grafted patch revealed no aneurysmal dilatation. Microscopic examination revealed, in most of the cardiac patches, a complete disappearance of the scaffold and its replacement by a consistent tissue composed of myofibroblasts embedded in collagen bundles. The cardiac patch was enriched with a relatively large number of infiltrating blood vessels. In conclusion, cardiac patches generated in the peritoneum were developed into consistent tissue patches with properties to seal and correct myocardial defects. Our study also offers a viable rat model for screening and evaluating new concepts in cardiac reconstruction and engineering.
INTRODUCTION
model of heterotopic heart transplantation offers the ability to operate on an explanted donor organ without using cardiopulmonary bypass or cardiovascular com-Tissue engineering of viable cardiac patches with a potential to grow and remodel may provide a new solu-promise (8).
For full free wall reconstruction, a tissue-engineered tion to the serious problems of heart donor shortage and pediatric heart transplantation (4). However, to advance patch should be muscular, vascularized, elastic, and ideally possess contractile potential. As this goal is hard to this clinically relevant strategy, there is a need for animal models to test the scientific and clinical feasibility achieve using current in vitro techniques, new strategies are warranted (4,12). The aim of our study was, there-of tissue engineering.
Much of the encouraging data in the field of cardio-fore, to develop a novel cardiac patch to replace damaged heart muscle. Accordingly, a cardiac patch was vascular tissue engineering have been obtained from small animal models (7, 9, 11, 16) . The small-animal model developed by seeding fetal cardiomyocytes within macroporous alginate scaffolds followed by their vasculari-has many advantages, such as the accessibility of inbred animals, availability of autologous-like cell sources, and zation into the rat peritoneal cavity prior to transplantation onto a damaged donor heart. The performance of low cost. Nonetheless, cardiac tissue engineering in the murine model is limited by difficulties in replacing full-the novel cardiac patch was tested in a rat model of heterotopic heart transplant, which enables replacement of thickness left ventricular (LV) free wall. Thus, the rat a full-thickness free wall. Our model can be thus useful tology and hematoxylin-eosin (H&E) staining of thin cross sections of the cardiac constructs. for screening and evaluating new strategies and methods of cardiac tissue engineering.
Surgical Procedures
Peritoneal transplantation of the seeded scaffold was MATERIALS AND METHODS performed 4 days after cell seeding in the alginate scaf-This study was performed in accordance with the fold and cultivation in vitro. Lewis rats were anestheguidelines of The Animal Care and Use Committee of tized with ketamine (100 mg/kg), xylazine (10 mg/kg), the Tel-Aviv University, which conforms to the policies and, under sterile conditions, a small incision was made of the American Heart Association.
in the shaved abdominal wall and two or three cellseeded or empty scaffolds were placed inside the perito-Cardiac Cell Isolation neal cavity of each animal. Fetal cardiomyocytes (16 days of gestation) from
One to 4 weeks after peritoneal implantation, hetero-Lewis rats were used to seed the alginate scaffold.
topic heart transplantation was performed in Lewis rats Hearts were removed and placed in cold dissociation (weighting ϳ250 g), using the technique described by buffer. The ventricles were cut into 1-2-mm cubes and Ono and Lindsey (13). The donor rat underwent a middissociated through gentle stirring in a solution of proline abdominal and chest incision separating the anterior teolytic enzymes (RDB, obtained from Israel Institute chest and the diaphragm; the anterior rib cage was for Biological Research, Ness-Ziona, Israel), prepared hinged, exposing the heart. UW (Viaspan, DuPont) from a fig tree extract. The RDB was diluted 1:100 in cardioplegic solution, containing heparin (100 U/10 ml), Ca 2+ -and Mg 2+ -free PBS at 25°C and incubated with the was administered through the inferior vena cava in order tissues pieces for a few cycles of 10 min each (6). The to arrest and preserve the heart. In the recipient rat, a mixture was centrifuged at 300 × g for 5 min and the long abdominal incision was performed, exposing the supernatant was discarded. The cells were resuspended abdominal aorta and the inferior vena cava from a short in Dulbecco's modified Eagle's medium (DMEM) consegment just below the renal arteries to the point chosen taining 10% horse serum (Biological Industries, Kibbutz for the anastomosis. The abdominal vessels were Beit Haemek, Israel) and 2% chick embryo extract (Bioclamped, the ascending aorta of the donor heart was logical Industries) and preplated onto a 60-mm dish for anastomosed to the abdominal aorta using 8/0 prolene 15 min at 37°C. An aliquot of the nonattached cells, suture, and the pulmonary artery was anastomosed to the >70% of which were cardiomyocytes (5), was counted inferior vena cava using 10/0 prolene suture. A longituand was used for seeding the alginate scaffold.
dinal ventriculotomy was performed either on the left or right ventricular free wall and the peritoneal-generated 3D Culturing Within Alginate Scaffolds tissue-engineered patch was sutured to seal the defect using 8/0 prolene suture. After declamping the abdomi-The isolated cardiac cells were seeded, at a concentration of 1 × 10 6 cells per scaffold, within cylindrical nal vessels, the transplanted heart spontaneously resumed contractions and the abdominal cavity was closed using alginate scaffolds (6 × 1 mm, diameter × height ( Fig.  1A ) placed in a 96-well plate. The macroporous scaf-an absorbable 2/0 Vicryl running suture. folds were prepared from a 1% (w/v) solution of sodium Evaluate Remodeling and Contractility alginate (LVG; NovaMatrix, FMC Biopolymers, Dramby Echocardiography men, Norway) cross-linked with a 0.3% (w/v) solution of D-gluconic acid hemicalcium salt, and subjected to a An echocardiography study designed to evaluate the performance of the heart transplant was performed on controlled freeze-dry procedure (15). The cells were seeded into the dry alginate scaffolds by dropping the eight animals, 7 to 14 days after heart transplantation. Rats were anesthetized as described above, the abdomen cardiac cell suspension on top of the scaffold. Due to their hydrophilic nature, the scaffolds were easily wetted was shaved, and the rats were placed supine. Transabdominal echocardiograms were performed with a com-by the culture medium such that cell seeding was efficient (5). The cultures were incubated in a humidified mercially available echocardiography system equipped with 12-MHz phased-array transducer (S12, Sonos atmosphere of 5% CO 2 and 95% air at 37°C, with daily medium changes. The cell constructs were followed mi-5500, Hewlett-Packard). The heart was imaged in the 2D mode in at least two planes of the short axis view. croscopically for 4 days before implantation into the peritoneal cavity. The viability and metabolic activities LV function was semiquantitatively assessed by an experienced echocardiographer using visual grading of of the cardiac cell constructs were tested by the MTT viability assay (5). Cell distribution was assessed by his-global and regional contraction (1) .
Histological and Immunohistochemical Examination
(MHC, Zymed-Invitrogen), or actinin (Sigma) and counterstained with hematoxylin. Representative samples of the cell-seeded scaffolds RESULTS were fixed and immunostained 1 week after implantation in the peritoneum. Four weeks after transplantation, Overall, 52 syngeneic Lewis rats were included in our study, designed to establish the model and evaluate recipient animals were killed by phenobarbital overdose. The hearts were harvested, sectioned, and processed for cardiac patch performance. In a pilot study aimed at establishing the feasibility of blood vessel penetration into histological and immunohistochemical examination. Adjacent blocks of the peritoneal-generated cardiac patch the macroporous scaffold and technical aspects of the method, each of two rats were implanted with two to or harvested heart were embedded in paraffin, sectioned into 5-µm slices, and stained with H&E or Masson tri-three unseeded (empty) scaffolds, inserted into the peritoneal cavity. Twenty rats were used as "bioreactors" chrome for collagen. Serial sections were immunolabeled with antibodies against the smooth muscle α-actin for the peritoneal-generated cardiac patches; two to three cell constructs were implanted per rat. Fifteen hetero-isoform (SMA, Sigma, St. Louis, MO), sarcomeric actin (Zymed-Invitrogen, Carlsbad, CA), myosin heavy chain topic heart transplantations were performed using 30 rats (15 donors and 15 recipients). In the recipients, the defects were either in the LV (n = 6) or RV (n = 9) wall. Five rats died within 24 h of peritoneal implantation of the seeded scaffolds because of surgical complications. There were no perioperative deaths in the rats that underwent heterotopic heart transplantation and surgical reconstruction, nor were any patch failures observed.
Cardiac Cell Constructs
The alginate scaffolds used in the present study displayed a highly porous structure (>90%) with interconnected pores and pore sizes that ranged between 50 and 100 µm in diameter, as judged by scanning electron microscope (SEM) examination (Fig. 1B) . These properties should enable the penetration of blood vessels into the macroporous matrix, as well as its vascularization (14). The alginate scaffolds were sufficiently stable in culture and were easily handled. Seeding of cardiac cells onto the alginate scaffolds was efficient due to the hydrophilic nature of the alginate material, which allowed rapid wetting of the matrix by the culture medium. The viable cells were uniformly distributed throughout the scaffold volume and were mainly located within the scaffold pores in small clusters (Fig. 1C ). After 4 days in culture and following validation of cell viability, the cardiac cell constructs were implanted into the peritoneum.
A Peritoneal-Generated Cardiac Patch
The pilot study intended to examine blood vessel entry into the unseeded alginate scaffolds after implantation into the peritoneum. Histological examination of 1-2-week engrafted scaffolds revealed extensive blood vessel in-growth into the entire volume of the scaffold, validating its interconnecting pore structure.
Visual inspection of the peritoneal-generated cardiac patches, examined 1 week after implantation, revealed coverage by a thin connective tissue, enriched with blood vessels (Fig. 2A) . The extensive neovascularization into the cardiac patch emerged from the neighboring peritoneal network. Microscopic examination of cross sections of the peritoneal-generated cardiac patch, positively stained for SMA, revealed the presence of (Fig. 3) concentrates on the border between the transated cardiac patch (short arrow) was sutured to seal the defect.
planted cardiac patch (G) and the host myocardium (H), with (B, C) One month after heterotopic heart transplantation of the some remnant of the alginate scaffold at the anchoring site cardiac patch, H&E-stained cross sections revealed that the seen. (B) A closer look at the transplanted cardiac patch resite of LV ventriculotomy (thin arrow) and LV cavity were veals that extensive areas are composed of fibroblasts and exsealed by the cardiac patch (thick arrow). In (B), a complete tracellular matrix. (C) Masson trichrome staining revealed exintegration of the cardiac patch with the LV wall (arrow) is tensive areas of collagen bundles in the patch. The collagen seen; the patch is covered by the remaining peritoneal adhestained blue, while the host myocardium (H) stained deep red. sion (P). In (C), the cardiac patch is still seen with small acellular areas, although most of its area is cell populated. The anchorage site of the cardiac patch to the myocardium is identified (long arrow). connective tissue infiltrated with new large blood vessels, particularly in the periphery of the graft (Fig. 2B) . In the center of the patch, the blood vessels were smaller in size (Fig. 2C) . Their positive staining for SMA points, however, to pericyte and smooth muscle cell coverage of the vessel, and to its maturity. Myocardial fibers or typical sarcomeres were not visible in detectable numbers in the peritoneal-generated cardiac patch.
Heterotopic Heart Transplantation
One month after transplantation of the peritonealgenerated cardiac patch onto heterotropic rat heart, macroscopic examination of H&E-stained cross sections revealed, in most cases, the presence of the cardiac patch sealing the LV or RV defect (Fig. 3) . In three cases, the cardiac patch was not identified, either because it underwent complete integration into the ventricular wall (n = 2) or because it was detached (n = 1). Nonetheless, the LV or RV defect was sealed in each case (Fig. 3B) . With most of the transplanted cardiac patches, tissue ingrowth onto the scaffolds was nearly complete. We identified small acellular areas in the center of only four of nine RV grafts and two of six LV grafts (Fig. 3C) .
Microscopically, the heart-transplanted cardiac patches were populated with newly formed capillaries and arterioles embedded within a confluent collagen bundle matrix that stained positive for Masson trichrome (Fig. 4) . Typical myofibroblasts and infiltrated macrophages were also present. At many anchorage sites, the cardiac patch showed complete integration with the host tissue, with the specimens showing almost complete disappearance of the scaffold (Fig. 4A) . The fibroblasts within the cardiac patches were stained intensely for SMA ( Fig. 5 ). Staining for myogenic proteins, such as slow MHC, sarcomeric actin, or actinin was not apparent in the implanted cardiac patches, 4 weeks after transplantation (Fig. 5) .
Echocardiography
Semiquantitative two-dimensional echocardiographic assessment showed good global LV function of the abdominal transplanted heart without any segmental wall motion abnormalities in the segment of the patch grafting or other areas in seven of the eight animals studied (Fig. 6 ). LV contractility appeared synchronized and smooth. Only one animal exhibited moderate global LV dysfunction, compatible with a clinical and histological 
DISCUSSION
We demonstrate the use of a peritoneal-generated cardiac patch to replace a full-thickness section of the ventricle free wall in a rat model of heterotopic heart and an extensive blood vessel network that could add to the firmness and confluence of the tissue-engineered transplantation. The cardiac patch was developed by seeding fetal cardiomyocytes within macroporous algi-cardiac patch. Another advantage of using the peritoneal cavity as a bioreactor for tissue engineering is the cre-nate scaffolds, followed by implantation into the rat peritoneum cavity prior to transplantation onto the heter-ation of a cardiac patch from autologous cells in the host environment. otopic heart. The construction of the cardiac patch in vivo resulted in a consistent tissue due to the extensive The peritoneal-generated cardiac patch was tested in the heterotopic heart model, which enables the replace-cell in-growth from the host and the extensive vascularization of the patch. Such cardiac patches may thus pos-ment of a full-thickness wall. The model was initially developed by Krupnick et al. (8), who employed scaf-sess the mechanical and elastic properties and tissue consistency required to repair LV defects.
folds made of poly(tetrafluoroethylene), poly(lactide) mesh, and type I and IV collagen hydrogel and seeded The use of the peritoneum for tissue engineering offers several advantages, including the maintenance of with mesenchymal stem cells. To facilitate implantation of the cell construct into the myocardium, the construct cell construct sterility and contribution to two critical properties of the cardiac patch, namely elasticity and in their study was attached to an identically sized support layer composed of either a biodegradable or syn-mechanical strength, traits that are necessary for the long-term success of the cardiac patch. By growing the thetic material. In our model, the tissue engineering of the cardiac patch in the peritoneal cavity resulted in a neotissues in the peritoneal cavity, serving as a "natural bioreactor," it is possible to create an environment that well-built patch, which obviates the need for any such back-up support layer. Furthermore, our results reveal duplicates conditions required for the development of normal tissue. The neotissues are formed with greater that the peritoneal-generated cardiac patch was able to seal the ventricular (LV or RV) defect, enabling good collagen content, making them better suited for the active condition of the cardiac work load. Our results also global functioning of the wall. An interesting finding of this study is that the perito-showed that the peritoneal-generated cardiac patch was colonized and populated by autologous myofibroblasts neal-generated cardiac patch lacks the characteristic fea-
